[1] |
王灵站, 王立群, 王俊梅, 于广海, 毕伏龙. 二甲双胍经线粒体及内质网对骨骼肌减少症干预作用的研究进展. 解剖学杂志, 2018, 41(2): 220-224.
|
|
WANG L Z, WANG L Q, WANG J M, YU G H, BI F L. Advance in the research on the treatment of sarcopenia with metformin via mitochondria and endoplasmic reticulum. Chinese Journal of Anatomy, 2018, 41(2): 220-224. (in Chinese)
|
[2] |
WANG G Q, WANG Y, XIONG Y, CHEN X C, MA M L, CAI R, GAO Y, SUN Y M, YANG G S, PANG W J. Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a. Scientific Reports, 2016, 6: 21865.
doi: 10.1038/srep21865
|
[3] |
LI R Y, LI B J, CAO Y, LI W J, DAI W L, ZHANG L L, ZHANG X, NING C B, LI H Q, YAO Y L, TAO J L, JIA C, WU W J, LIU H L. Long non-coding RNA Mir22hg-derived miR-22-3p promotes skeletal muscle differentiation and regeneration by inhibiting HDAC4. Molecular Therapy - Nucleic Acids, 2021, 24: 200-211.
doi: 10.1016/j.omtn.2021.02.025
|
[4] |
PITTAYAPRUEK P, MEEPHANSAN J, PRAPAPAN O, KOMINE M, OHTSUKI M. Role of matrix metalloproteinases in photoaging and photocarcinogenesis. International Journal of Molecular Sciences, 2016, 17(6): 868.
doi: 10.3390/ijms17060868
|
[5] |
CHENG Z Y, LIMBU M H, WANG Z, LIU J, LIU L, ZHANG X Y, CHEN P S, LIU B C. MMP-2 and 9 in chronic kidney disease. International Journal of Molecular Sciences, 2017, 18(4): 776.
doi: 10.3390/ijms18040776
|
[6] |
NILAND S, RISCANEVO A X, EBLE J A. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. International Journal of Molecular Sciences, 2021, 23(1): 146.
doi: 10.3390/ijms23010146
|
[7] |
CAREY P, LOW E, HARPER E, STACK M S. Metalloproteinases in ovarian cancer. International Journal of Molecular Sciences, 2021, 22(7): 3403.
doi: 10.3390/ijms22073403
|
[8] |
GROSS J, LAPIERE C M. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proceedings of the National Academy of Sciences of the United States of America, 1962, 48(6): 1014-1022.
|
[9] |
WANG X, KHALIL R A. Matrix metalloproteinases, vascular remodeling, and vascular disease. Advances in Pharmacology, 2018, 81: 241-330.
|
[10] |
DAS A, MONTEIRO M, BARAI A, KUMAR S, SEN S. MMP proteolytic activity regulates cancer invasiveness by modulating integrins. Scientific Reports, 2017, 7(1): 14219.
doi: 10.1038/s41598-017-14340-w
pmid: 29079818
|
[11] |
LEI H Q, LEONG D, SMITH L R, BARTON E R. Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration. American Journal of Physiology-Cell Physiology, 2013, 305(5): C529-C538.
doi: 10.1152/ajpcell.00051.2013
|
[12] |
SNYMAN C, NIESLER C U. MMP-14 in skeletal muscle repair. Journal of Muscle Research and Cell Motility, 2015, 36(3): 215-225.
doi: 10.1007/s10974-015-9414-4
pmid: 26025393
|
[13] |
MARINTCHEV A, WAGNER G. TRANSLATION INITIATION: Structures, Mechanisms and Evolution. Quarterly Reviews of Biophysics, 2004, 37(3/4): 197-284.
doi: 10.1017/S0033583505004026
|
[14] |
KAPP L D, LORSCH J R. The Molecular Mechanics of Eukaryotic Translation. Annual Review of Biochemistry, 2004, 73: 657-704.
pmid: 15189156
|
[15] |
HERNÁNDEZ G. On the Origin of the Cap-Dependent Initiation of Translation in Eukaryotes. Trends in Biochemical Sciences, 2009, 34(4): 166-175.
doi: 10.1016/j.tibs.2009.02.001
pmid: 19299142
|
[16] |
GRABER T E, HOLCIK M. Cap-Independent Regulation of Gene Expression in Apoptosis. Molecular Biosystems, 2007, 3(12): 825-834.
pmid: 18000559
|
[17] |
KOZAK M. The Scanning Model for Translation: An Update. Journal of Cell Biology, 1989, 108(2): 229-241.
pmid: 2645293
|
[18] |
BROWNE G J, PROUD C G. Regulation of Peptide-Chain Elongation In Mammalian Cells. European Journal of Biochemistry, 2002, 269(22): 5360-5368.
doi: 10.1046/j.1432-1033.2002.03290.x
pmid: 12423334
|
[19] |
CIECHANOVER A. Intracellular protein degradation from a vague idea through the lysosome and the ubiquitin-proteasome system and on to human diseases and drug targeting: Nobel lecture, december 8, 2004. Annals of the new york academy of sciences, 2007, 1116(1): 1-28.
doi: 10.1196/annals.1402.078
|
[20] |
WANG Y, ZHAO Z J, KANG X R, BIAN T, SHEN Z M, JIANG Y, SUN B, HU H B, CHEN Y S. lncRNA DLEU2 acts as a miR-181a sponge to regulate SEPP1 and inhibit skeletal muscle differentiation and regeneration. Aging, 2020, 12(23): 24033-24056.
doi: 10.18632/aging.v12i23
|
[21] |
CAI R, ZHANG Q, WANG Y Q, YONG W L, ZHAO R, PANG W J. Lnc-ORA interacts with microRNA-532-3p and IGF2BP2 to inhibit skeletal muscle myogenesis. Journal of Biological Chemistry, 2021, 296: 100376.
doi: 10.1016/j.jbc.2021.100376
|
[22] |
CHEN M M, LI X, ZHANG X J, LI Y, ZHANG J X, LIU M H, ZHANG L L, DING X B, LIU X F, GUO H. A novel long non-coding RNA, lncKBTBD10, involved in bovine skeletal muscle myogenesis. In Vitro Cellular & Developmental Biology - Animal, 2019, 55(1): 25-35.
doi: 10.1007/s11626-018-0306-y
|
[23] |
LI Z H, CAI B L, ALI ABDALLA B, ZHU X N, ZHENG M, HAN P G, NIE Q H, ZHANG X Q. LncIRS1 controls muscle atrophy via sponging miR-15 family to activate IGF1-PI3K/AKT pathway. Journal of Cachexia, Sarcopenia and Muscle, 2019, 10(2): 391-410.
doi: 10.1002/jcsm.v10.2
|
[24] |
MONDAL S, ADHIKARI N, BANERJEE S, AMIN S A, JHA T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. European Journal of Medicinal Chemistry, 2020, 194: 112260.
doi: 10.1016/j.ejmech.2020.112260
|
[25] |
NANDI S S, KATSURADA K, SHARMA N M, ANDERSON D R, MAHATA S K, PATEL K P. MMP9 inhibition increases autophagic flux in chronic heart failure. American Journal of Physiology Heart and Circulatory Physiology, 2020, 319(6): H1414-H1437.
doi: 10.1152/ajpheart.00032.2020
|
[26] |
FU C K, CHANG W S, TSAI C W, WANG Y C, YANG M D, HSU H S, CHAO C Y, YU C C, CHEN J C, PEI J S, BAU D T. The association of MMP9 promoter Rs3918242 genotype with gastric cancer. Anticancer Research, 2021, 41(7): 3309-3315.
doi: 10.21873/anticanres.15118
|
[27] |
XUE J C, ZHOU H Y, YU L S Y, WU Y Y. Effect of IL-8 on hepatocellular carcinoma-associated metastasis by targeting MMP9 in mice. Translational Cancer Research, 2022, 11(7): 2050-2060.
doi: 10.21037/tcr
|
[28] |
KUMAR L, BISEN M, KHAN A, KUMAR P, PATEL S K S. Role of matrix metalloproteinases in musculoskeletal diseases. Biomedicines, 2022, 10(10): 2477.
doi: 10.3390/biomedicines10102477
|
[29] |
LI H, MITTAL A, MAKONCHUK D Y, BHATNAGAR S, KUMAR A. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Human Molecular Genetics, 2009, 18(14): 2584-2598.
doi: 10.1093/hmg/ddp191
pmid: 19401296
|
[30] |
KHERIF S, LAFUMA C, DEHAUPAS M, LACHKAR S, FOURNIER J G, VERDIÈRE-SAHUQUÉ M, FARDEAU M, ALAMEDDINE H S. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdxMuscles. Developmental Biology, 1999, 205(1): 158-170.
doi: 10.1006/dbio.1998.9107
|
[31] |
YAMADA H, SAITO F, FUKUTA-OHI H, ZHONG D, HASE A, ARAI K, OKUYAMA A, MAEKAWA R, SHIMIZU T, MATSUMURA K. Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Human Molecular Genetics, 2001, 10(15): 1563-1569.
pmid: 11468274
|
[32] |
MATSUMURA K, ZHONG D, SAITO F, ARAI K, ADACHI K, KAWAI H, HIGUCHI I, NISHINO I, SHIMIZU T. Proteolysis of β-dystroglycan in muscular diseases. Neuromuscular Disorders, 2005, 15(5): 336-341.
doi: 10.1016/j.nmd.2005.01.007
|
[33] |
CHENETTE D M, CADWALLADER A B, ANTWINE T L, LARKIN L C, WANG J H, OLWIN B B, SCHNEIDER R J. Targeted mRNA decay by RNA binding protein AUF1 regulates adult muscle stem cell fate, promoting skeletal muscle integrity. Cell Reports, 2016, 16(5): 1379-1390.
doi: 10.1016/j.celrep.2016.06.095
|
[34] |
ZIMOWSKA M, OLSZYNSKI K H, SWIERCZYNSKA M, STREMINSKA W, CIEMERYCH M A. Decrease of MMP-9 activity improves soleus muscle regeneration. Tissue Engineering Part A, 2012, 18(11/12): 1183-1192.
doi: 10.1089/ten.tea.2011.0459
|